Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Cell & gene therapy

Research Field Drug delivery

Recognizing Friend from Foe

| Werner Cautreels

Solutions are needed to teach the immune system to recognize biological drugs as partners, not plunderers.

Tools & Techniques Cell & gene therapy

Babies’ Breath

| Jegen Kandasamy

Research reveals a potential noninvasive predictor of bronchopulmonary dysplasia risk in preterm infants

Research Field Drug delivery

Image of the Month

A scanning electron micrograph of porous poly lactic-co-glycolic acid (PLGA) microparticles.

Outside the Lab Personalized medicine

"Sexy" Needs Substance

| Rajesh Rao

We need to explain the context when using “grab bag” phrases in science and medicine

Research Field Cell & gene therapy

From Bench to Bedside and Back Again

| Roisin McGuigan

Sitting Down With... James Wilson, Professor and Director, Rose H. Weiss Orphan Disease Center.

Tools & Techniques Cell & gene therapy

Stem Cell Stepping Stones

| Roisin McGuigan

A new treatment for STAT1 mutations has a disappointingly low success rate – but shows potential.

Research Field Biomedical engineering

Lab-Grown Bone

| Roisin McGuigan

Engineered biomaterial supports donor blood marrow.

Tools & Techniques Cell & gene therapy

Small(er) Sequence, Big(ger) Promise

| Ruth Steer

CRISPR gene editing with a newly characterized orthologue may bring the approach closer to the clinic.

Research Field Cell & gene therapy

Stem Cells for Stroke Recovery

| William Aryitey

A phase II trial shows the safety and efficacy of progenitor cells in stroke victims

Research Field Cell & gene therapy

Retinoic Regeneration

| William Aryitey

The regenerative ability of an immune pathway has been revealed

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register